Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts

American Journal of Transplantation

Volumn 11, Issue 4, 2011, Pages 832-840

  Riella, L V ^a   Watanabe, T ^a   Sage, P T ^a   Yang, J ^a   Yeung, M ^a   Azzi, J ^a   Vanguri, V ^b   Chandraker, A ^a   Sharpe, A H ^a   Sayegh, M H ^a   Najafian, N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Costimulation; endothelium; heart; PDL1; rejection; tolerance

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN; PROGRAMMED DEATH 1 LIGAND 1;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEMATOPOIETIC CELL; HISTOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD80; BONE MARROW; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IMMUNOENZYME TECHNIQUES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79953239218     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03451.x     Document Type: Article

References (22)

1. Li XC, Rothstein DM, Sayegh MH,. Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009; 229: 271-293.
2. Eppihimer MJ, Gunn J, Freeman GJ, et al,. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002; 9: 133-145. (Pubitemid 135684689)
3. Keir ME, Butte MJ, Freeman GJ, Sharpe AH,. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704. (Pubitemid 351600389)
4. Keir ME, Liang SC, Guleria I, et al,. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203: 883-895.
5. Latchman YE, Liang SC, Wu Y, et al,. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci USA 2004; 101: 10691-10696. (Pubitemid 38955804)
6. Tanaka K, Albin MJ, Yuan X, et al,. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol 2007; 179: 5204-5210.
7. Yang J, Riella LV, Boenisch O, et al,. Paradoxical functions of B7:CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am J Transplant 2009; 9: 2837-2844.
8. Grabie N, Delfs MW, Westrich JR, et al,. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest 2003; 111: 671-680. (Pubitemid 36278585)
9. Ito T, Ueno T, Clarkson MR, et al,. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 2005; 174: 6648-6656. (Pubitemid 40705625)
10. Sandner SE, Clarkson MR, Salama AD, et al,. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 2005; 174: 3408-3415. (Pubitemid 40354046)
11. Yang J, Popoola J, Khandwala S, et al,. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008; 117: 660-669.
12. Wang W, Carper K, Malone F, et al,. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection. Transplantation 2008; 86: 836-844.
13. Grabie N, Gotsman I, DaCosta R, et al,. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ Tcell mediated injury in the heart. Circulation 2007; 116: 2062-2071. (Pubitemid 350023752)
14. Morita M, Fujino M, Jiang G, et al,. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant 2010; 10: 40-46.
15. Ueno T, Tanaka K, Jurewicz M, et al,. Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J Am Soc Nephrol 2009; 20: 535-544.
16. Rodig N, Ryan T, Allen JA, et al,. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003; 33: 3117-3126. (Pubitemid 37428344)
17. Pober JS,. Immunobiology of human vascular endothelium. Immunol Res 1999; 19: 225-232. (Pubitemid 29401379)
18. Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH,. Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol 1997; 159: 3247-3256. (Pubitemid 127482083)
19. Kreisel D, Krupnick AS, Balsara KR, et al,. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol 2002; 169: 6154-6161. (Pubitemid 36903460)
20. Mandelbrot DA, Kishimoto K, Auchincloss H Jr,., Sharpe AH, Sayegh MH,. Rejection of mouse cardiac allografts by costimulation in trans. J Immunol 2001; 167: 1174-1178. (Pubitemid 32703110)
21. Kreisel D, Krupnick AS, Gelman AE, et al,. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition. Nat Med 2002; 8: 233-239. (Pubitemid 34250100)
22. Krupnick AS, Gelman AE, Barchet W, et al,. Murine vascular endothelium activates and induces the generation of allogeneic CD4 + 25+Foxp3+ regulatory T cells. J Immunol 2005; 175: 6265-6270. (Pubitemid 41598864)